ASXC - Asensus Surgical Non-GAAP EPS of -$0.07 beats by $0.01 revenue of $1.07M misses by $0.23M

Asensus Surgical press release (NYSE:ASXC): Q1 Non-GAAP EPS of -$0.07 beats by $0.01. Revenue of $1.07M (-48.6% Y/Y) misses by $0.23M. The Company had cash, cash equivalents, short-term and long-term investments, excluding restricted cash, of approximately $118.5 million at March 31, 2022. During the second half of 2022, the Company expects to achieve the following commercial and regulatory milestones: Full scale commercialization of articulating instruments globally File a 510(k) for FDA clearance of Senhance for pediatric indication Receive CE Mark for expanded machine vision capabilities for the Intelligent Surgical Unit™ Shares -2.27%.

For further details see:

Asensus Surgical Non-GAAP EPS of -$0.07 beats by $0.01, revenue of $1.07M misses by $0.23M